IBTA

The IBTA is an alliance of the support, advocacy and information groups for brain tumour patients and carers around the world.

[IBTA @theIBTA]

The official report on the International Patient Advocacy Symposium on Brain Metastases is available here:
https://t.co/H3BKQTqF1u
#brainmetastases #brainmets #braintumour

[IBTA @theIBTA]

The IBTA e-News Roundup for September/October 2025 - https://t.co/HhLUfBymBj

[IBTA @theIBTA]

Vorasidenib approved to treat patients 12 years and older with grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation https://t.co/QMLXAi7NEN

[IBTA @theIBTA]

The IBTA e-News Roundup for August 2025 - https://t.co/uDWmlHZN3n

[IBTA @theIBTA]

Proton Therapy Benefits IDH-Mutant Glioma Patients https://t.co/gMTXQHNKCi

[IBTA @theIBTA]

The IBTA e-News Roundup for July 2025 - https://t.co/4uy8Ts2BrH

[IBTA @theIBTA]

Glioblastoma Funding Rises as Nonprofits Drive Interest and Pharma Returns to the Table https://t.co/2au6kxQSTx

[IBTA @theIBTA]

Servier Receives Positive CHMP Opinion for VORANIGO® (vorasidenib) for the Treatment of Adults and Adolescents with Grade 2 IDH-mutant Diffuse Glioma
https://t.co/NSaYkpUmzm

[IBTA @theIBTA]

The IBTA e-News Roundup for June 2025 - https://t.co/YzFGYdYi6K

[IBTA @theIBTA]

Machine learning can improve detection of brain cancer from blood https://t.co/vHbhxhcTuJ

[IBTA @theIBTA]

The IBTA e-News Roundup for May 2025 - https://t.co/rLxKeErbTB

[IBTA @theIBTA]

Could electric fields supercharge immune attack on the deadliest form of brain cancer? https://t.co/pS5nP4vZKL

[Brain Tumour Research @braintumourrsch]

Our thoughts are with the loved ones of Dr Stu Farrimond, who has sadly passed away.

We are so grateful for everything he did to raise awareness of this cruel disease & fight for better outcomes for those affected.

@theIBTA #BrainTumourResearch #TogetherWeWillFindACure

[GLIORESOLVE @Glioresolve]

The GLIORESOLVE project was featured in the 2024/2025 World Edition of the Brain Tumour Magazine, published by the @theIBTA You can read the full publication here https://t.co/kXO0k0q8zX and our article is on Pg 23!

[IBTA @theIBTA]

There is no cure for brain cancer. More research is desperately needed #RareDiseaseDay2025

[IBTA @theIBTA]

The IBTA e-News Roundup for January/February 2025 - https://t.co/HYXjxji1NS

[IBTA @theIBTA]

The IBTA e-News Roundup for January/February 2025 - https://t.co/HYXjxji1NS

[European Cancer Organisation @EuropeanCancer]

The #EUCancerPlan has been a success for member states, yet so much remains to be done. 👈

Inequalities in reach and accessibility of cancer care persist. The solution: concrete, data-driven insights to drive robust policy action. 📈

The #EuropeanCancerPulse provides vital information that governments, organisations and advocates need to identify weak points and act on them. 💻

Take a look. 🔗 https://t.co/4FNdocG4TR

Read our country reports and see for yourself. 📃 https://t.co/IEm2zi8LOM

[EORTC @EORTC]

🚀 We are proud to announce that @sisaqol final recommendations are here!

🎗️This global initiative, co-led by EORTC & @Boehringer, sets new standards for analysing patient-reported outcomes in cancer trials.

Learn more: https://t.co/XNXDq28ZmN
#CancerResearch #QualityofLife